Abstract: A system can cause display of a mixed reality interface including multiple graphical tiles in a particular chronological order. The system can detect a motion-based gesture of a user relative to the mixed reality interface while displaying the multiple graphical tiles, and correlate the motion-based gesture of the user to the display of the mixed reality interface to move a particular graphical tile to a new location among the multiple graphical tiles. In response to the motion-based gesture, the system can virtually displace another graphical tile of the multiple graphical tiles to accommodate the new location of the particular graphical tile and cause display, through the mixed reality interface, of the multiple graphical tiles arranged in a new order.

Abstract: Computer vision and deep learning techniques are leveraged to detect behavior patterns in transaction histories. A transaction timeline is built for a series of transactions, e.g., financial, and a graphic image is constructed representing the transaction timeline. The graphic image is then matched to a known behavior pattern using a cognitive system. The cognitive system is trained with historical timeline images having associated labels. In one example the graphic image is a bar chart and each financial transaction is represented as a bar in the bar chart having a height proportional to a transaction amount, the bar being located along a time axis of the bar chart according to the transaction date and being color coded according to the transaction type.

Abstract: Compositions containing quaternary compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, and the composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Also, ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions.

Abstract: Compositions containing quaternary compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, and the composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Also, ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of a ClpB protein or an effective amount of a bacterium that expresses the ClpB protein.

Abstract: The present invention relates to method of preventing, treating or attenuating obesity-related manifestations in a human or non-human mammal subject in need thereof, said method comprising orally administering to the subject a composition comprising an effective amount Hafnia alvei probiotics; wherein said obesity-related parameters are selected from the group of hyperphagia, increased fat mass on lean mass ratio, increased waist circumference, postprandial hyperglycemia, fasting hyperglycemia and hypercholesterolemia.

Abstract: Methods of treating inflammation, in particular obesity, inducing satiation, prolonging satiety, and stimulating weight loss in a subject in need thereof, including the administration of a Brassicaceae protein extract. The Brassicaceae protein extract may be administered in the form of a dietary supplement or a food composition, either of which may include at least one additional ingredient.

Abstract: A semantic, machine readable language part that supports the specification of features is used by an engine that interprets that language to produce the features based on the raw data. In this way, the model developer can specify the measurement columns (for example, data fields), to obtain the dimensions from which the engine can compute the multiple combinations of features possible based on this set of input fields. This computation of features can be used to perform machine learning (ML) training and/or scoring algorithms (for example, ML algorithms for fraud detection).

Abstract: In an approach for optimizing an open feature library, a processor identifies redundancy among a set of features, the set of features previously executed in a machine learning model. A processor performs a predecessor evaluation, the predecessor evaluation including recognizing a feature in the set of features being executed and analyzing an impact of making an upstream feature configuration change relating to the feature. A processor performs a successor evaluation, the successor evaluation including recognizing the feature in the set of features being executed and analyzing an impact of making a downstream feature configuration change relating to the feature. A processor rates the feature against a goal, the goal including overall execution time and overall execution footprint in the machine learning model. A processor updates a state of the feature based on the predecessor evaluation, the successor evaluation, and the feature rating.

Abstract: In an approach for managing an open feature library, a processor collects feature metadata from a data source, the feature metadata being data related to features for training a machine learning model. A processor builds a feature pipeline for the features based on the collected feature metadata. The feature pipeline may be a set of defined and active features. A processor executes the feature pipeline including computing the features. A processor executes a machine learning model using the computed features. A processor evaluates the features and corresponding model results.

Abstract: A pharmaceutical or nutraceutical composition, including a Hafnia alvei strain probiotic composition; the strain expressing the ClpB protein; in association with zinc bisglycinate and/or chrome picolinate. Additionally, oral dosage forms of the pharmaceutical or nutraceutical composition including the Hafnia alvei strain probiotic composition in association with zinc bisglycinate and/or chrome picolinate.

Abstract: A composition essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein; wherein the ClpB protein is in an amount of at least 0.7% (w/w) in weight relative to the total weight of the composition; and the ratio of the total number of Hafnia alvei Colony Forming Units to the total Hafnia alvei cell number ranges from 10?4 to 0.8. Also, oral dosage forms, namely gastro-resistant capsules including the composition of essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein.

Abstract: Computer vision and deep learning techniques are leveraged to detect behavior patterns in transaction histories. A transaction timeline is built for a series of transactions, e.g., financial, and a graphic image is constructed representing the transaction timeline. The graphic image is then matched to a known behavior pattern using a cognitive system. The cognitive system is trained with historical timeline images having associated labels. In one example the graphic image is a bar chart and each financial transaction is represented as a bar in the bar chart having a height proportional to a transaction amount, the bar being located along a time axis of the bar chart according to the transaction date and being color coded according to the transaction type.

Abstract: Methods of treating inflammation, in particular obesity, inducing satiation, prolonging satiety, and stimulating weight loss in a subject in need thereof, including the administration of a Brassicaceae protein extract. The Brassicaceae protein extract may be administered in the form of a dietary supplement or a food composition, either of which may include at least one additional ingredient.

Abstract: Compositions containing quaternary compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, and the composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Also, ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions.

Abstract: The present invention relates to method of preventing, treating or attenuating obesity-related manifestations in a human or non-human mammal subject in need thereof, said method comprising orally administering to the subject a composition comprising an effective amount Hafnia alvei probiotics; wherein said obesity-related parameters are selected from the group of hyperphagia, increased fat mass on lean mass ratio, increased waist circumference, postprandial hyperglycemia, fasting hyperglycemia and hypercholesterolemia.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of Hafnia alvei.

Abstract: Compositions containing quaternary compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, and the composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Also, ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions.

Abstract: The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of a ClpB protein or an effective amount of a bacterium that expresses the ClpB protein.

Abstract: The present invention relates to ClpB expressing bacteria and their impact on obesity. The present invention relates to bacterial ClpB protein and ClpB expressing bacteria and their impact on eating disorders. The invention further relates to compositions comprising antibiotic directed against at least one ClpB expressing bacterium as well as probiotics not expressing ClpB protein and their use in the treatment or prevention of eating disorders. The invention also relates to diagnostic tools for determining whether a subject is likely to respond to a method of treating eating disorders and to methods of immunization against eating disorders.